Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial

Heart Rhythm

Volumn 8, Issue 4, 2011, Pages 536-540

  Cheng, Alan ^a,b   Nazarian, Saman ^a   Brinker, Jeffrey A ^a   Tompkins, Christine ^a   Spragg, David D ^a   Leng, Charles T ^a   Halperin, Henry ^a   Tandri, Harikrishna ^a   Sinha, Sunil K ^a   Marine, Joseph E ^a   Calkins, Hugh ^a   Tomaselli, Gordon F ^a   Berger, Ronald D ^a   Henrikson, Charles A ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NONE   (United States)

Author keywords

Anticoagulation; Bleeding; Heparin; ICD; Pacemaker; Stroke; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEFIBRILLATOR; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HEMATOMA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTICOAGULANTS; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE CARE; MALE; PACEMAKER, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; STROKE; TREATMENT OUTCOME; WARFARIN;

EID: 79953239765     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.12.016     Document Type: Article

References (22)

1. C. Marquie, G. DeGeeter, and D. Klug Post-operative use of heparin increases morbidity of pacemaker implantation Europace 8 2006 283 287 (Pubitemid 43905736)
2. M.C. Giudici, S.S. Barold, D.L. Paul, and P. Bontu Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy PACE 27 2004 358 360 (Pubitemid 38352516)
3. D.A. Garcia, S. Regan, and L.E. Henault Risk of thromboembolism with short-term interruption of warfarin therapy Arch Intern Med 168 2008 63 69
4. J.D. Douketis, P.B. Berger, and A.S. Dunn The perioperative management of antithrombotic therapy Chest 133 2008 299S 339S
5. G.F. Michaud, F. Pelosi, M.D. Noble, B.P. Knight, F. Morady, and S.A. Strickberger A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation J Am Coll Cardiol 35 2000 1915 1918 (Pubitemid 30342875)
6. D.J. Goldstein, W. Losquadro, and H.M. Spotnitz Outpatient pacemaker procedures in orally anticoagulated patients PACE 21 1998 1730 1734 (Pubitemid 28415469)
7. A.S. Al-Khadra Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients PACE 26 2003 511 514 (Pubitemid 36399207)
8. A. Tischenko, L.J. Gula, R. Yee, G.J. Klein, A.C. Skanes, and A.D. Krahn Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin Am Heart J 158 2009 252 256
9. J. De Bono, S. Nazir, N. Ruparelia, Y. Bashir, T. Betts, and K. Rajappan Perioperative management of anticoagulation during device implantationThe UK perspective PACE 33 2010 389 393
10. A.D. Krahn, J.S. Healey, C.S. Simpson, V. Essebag, S. Sivakumaran, and D.H. Birnie Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada Heart Rhythm 6 2009 1276 1279
11. C. Tompkins, A. Cheng, and D. Dalal Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation J Am Coll Cardiol 55 2010 2376 2382
12. I. Ahmed, E. Gertner, and W.B. Nelson Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation Heart Rhythm 7 2010 745 749
13. E. Jamula, J.D. Douketis, and S. Schulman Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide J Thromb Haemost 6 2008 1615 1621
14. J.M. Tolosana, P. Berne, and L. Mont Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial Eur Heart J 30 2009 1880 1884
15. C. Kearon, and J. Hirsh Management of anticoagulation before and after elective surgery N Engl J Med 336 1997 1506 1511
16. J. Hirsh, V. Fuster, J. Ansell, and J.L. Halperin AHA/ACC Foundation guide to warfarin therapy J Am Coll Cardiol 41 2003 1633 1652
17. J. Hirsh, S.S. Anand, J.L. Halperin, and V. Fuster Guide to anticoagulant therapy Heparin: a statement for healthcare professionals Circulation 103 2001 2994 3018 (Pubitemid 32578141)
18. H. Calkins, B.M. Ramza, and J. Brinker Prospective randomized comparison of the safety and effectiveness of placement of endocardial pacemaker and defibrillator leads using the extrathoracic subclavian vein guided by contrast venography versus the cephalic approach PACE 24 2001 456 464 (Pubitemid 32374866)
19. M. Robinson, J.S. Healey, and J. Eikelboom Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators PACE 32 2009 378 382
20. V. Parsonnet, A.D. Bernstein, and B. Lindsay Pacemaker-implantation complication rates: an analysis of some contributing factors J Am Coll Cardiol 13 1989 917 921 (Pubitemid 19087915)
21. A. Cheng, Y.F. Wang, J.P. Curtis, and P.D. Varosy Acute lead dislodgements and in-hospital mortality in patients enrolled in the NCDR ICD Registry J Am Coll Cardiol 56 2010 1651 1656
22. S. Thal, T. Moukabary, and R. Boyella The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation PACE 33 2010 385 388